Multiple Sclerosis

Probiotic Supplements Tied to Improved Outcomes in Relapsing Remitting MS

Brandon May

October 11, 2021

In a meta-analysis, researchers analyzed the effects of probiotics on disease progression, depression, general health, and anthropometric measures in patients with relapsing remitting multiple sclerosis.

Depressive Disorder, News

Depression, MS May Have Synergistic Effect on Mortality Risk

September 14, 2021

Depression in multiple sclerosis (MS) may increase the risks for incident vascular disease and mortality, and the effects of depression and MS on all-cause mortality appear to be synergistic.

Next post in Depressive Disorder

Multiple Sclerosis

Probiotic Supplements Tied to Improved Outcomes in Relapsing Remitting MS

Depression, MS May Have Synergistic Effect on Mortality Risk

Nursing Strategies for Managing Depression in Patients With Cancer